CHEST 2025: INSIDE LOOK
- This event has passed.
Evaluating Type 2 Inflammation in the Lower and Upper Airways and Results from Two Phase 4 Trials: VESTIGE & EVEREST
October 21, 2025 from 6:00 pm – 9:00 pm CDT
Marriott Marquis, Grand Horizon ABC
Sponsored by an educational grant from Sanofi
Program Description
Join Sanofi and Regeneron with renowned asthma specialists Dr. Mario Castro and Dr. Giselle Mosnaim as they examine how type 2 inflammation drives mucus plug formation, the impact of coexisting asthma on disease burden in patients with CRSwNP, and dupilumab data on mucus burden and clinical outcomes in patients with co-existing respiratory conditions.
Participate in the live Q&A session following the presentations to hear directly from global experts in pulmonology.
This is a non-CME event and does not qualify for CME or CE, or MOC credit. This event is not part of the official CHEST Annual Meeting 2025 conference sessions. This event is not an endorsement by CHEST and does not reflect the views or opinions of CHEST.
Presenters
Mario Castro, MD, MPH, FCCP
University of Kansas Medical Center
Professor/Adjunct Research Professor/Chief
Kansas City, Kansas
Giselle Mosnaim, MD, MS
NorthShore University HealthSystem
Attending
Evanston, Illinois
University of Chicago – The Pritzker School of Medicine
Clinical Associate Professor
Chicago, Illinois
